Shunchang Jiao

Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription

Gengyi Zou, Xiaotong Zhang, Lun Wang et al. · Theranostics · 2020 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

EZH2 contributes to the response to PARP inhibitors through its PARP-mediated poly-ADP ribosylation in breast cancer

Hirohiko YAMAGUCHI, Yi Du, Katsuya Nakai et al. · Oncogene · 2017 · 119 citations · Full text

Medicine, Molecular Biology, Oncology +11

PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling

Zhongyi Fan, Jingjing Duan, Lingxiong Wang et al. · Cancer Letters · 2019 · 108 citations

Medicine, Cancer Biology, Oncology +16

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs)

Ye Li, Zhibo Zhang, Yi Hu et al. · Frontiers in Oncology · 2020 · 94 citations · Full text

Medicine, Immunology, Oncology +17

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer

Yuan‐Sheng Zang, Chun Dai, Xiaoman Xu et al. · Cancer Medicine · 2019 · 63 citations · Full text

Medicine, Molecular Genetics, Oncology +17